← Open Payments lookup

VLADIMIR ZHODZISHSKY: Open Payments

NPI 1689319857 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$403 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $119 · 2025 $403

Food & beverage: $403
CompanyPaymentsAmount
SK Life Science, Inc.1$125
ARGENX US, INC.3$80
Amgen Inc.2$60
UCB, Inc.1$52
Alexion Pharmaceuticals, Inc.1$26
Axsome Therapeutics, Inc.1$21
Lundbeck LLC1$20
Biocodex, Inc.1$18

Products named: XCOPRI, VYVGART HYTRULO, UPLIZNA, Fintepla, ULTOMIRIS, Sunosi, VYEPTI, DIACOMIT.

Industry payments across MD — which companies pay providers there.